ATLAS Market profile
Menu
Atlas · Symbols · Stocks & Shares · BENF

Atlas market file · Equity · United States

BeneficientBENF

Last close
3.14
Change
+0.00%
96-bar range
2.745 – 4.49
As of
6 Aug 2026

Beneficient is a finance services issuer listed as BENF on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

Identity
Nasdaq Trader
Chart rail
TradingView
File state
Public profile
Atlas chart snapshot NASDAQ:BENF

Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.

4.54234.07993.61753.15512.692620 Mar29 May06 Aug

up candle   down candle

Latest close3.14
Day change+0.00%
Window high4.49
Window low2.745
96-bar change-17.59%
SnapshotDaily · 96 bars
As of2026-08-06 13:30 UTC

Weekly outlook: the last 104 weekly closes (-81.49% over the window).

17.55421.509819 Aug06 Aug

Source rail: Yahoo Finance chart API (BENF). This dated snapshot is the crawlable Atlas reference.

Live market viewTradingView · provider feed Open view

Open the attributed TradingView market view for BENF. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.

Loading the attributed market view...

Open full TradingView chart ->

At a glance

BENF public profile

Company

Finance services issuer. Beneficient is connected to current market context, cited company sources and its retained research file.

Market

Beneficient trades as BENF on NASDAQ. Beneficient (BENF) has a latest verified close of 3.14, unchanged, dated 6 Aug 2026.

Research

Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. Atlas files BENF under USA Stocks for browsing.

Institutional Market Wit ● Sourced Research File

Beneficient likes to describe itself as a "scalable, technology-enabled fiduciary financial services company" built to tap a $64 billion demand for liquidity and primary capital in alternative assets, but the balance sheet it actually collected looks like a student overdraft rather than a billion-dollar infrastructure play. Revenues clocked in at negative $39.1 million for the year to March 2026, which is a polite way of saying the company spent $39.1 million selling very little. Net income was negative $87.4 million, operating loss negative $166.5 million, and the cash and cash equivalents line sat at $2.5 million-enough to buy three and a half medium-sized houses or roughly 3.8 days of negative operating cash flow. The company's liabilities...

Unlock 25 custom research runs/day, 104-week candle charts, PDF report downloads & 500-symbol watchlist.

Unlock Atlas Pro — £12/mo Open Free Workstation Run →
Daily answer

What changed for Beneficient today

Open full report
BENF daily contextvalidated public digest14 source rail2026-08-07 02:40 UTC

Beneficient’s 10-K for the year to 31 March 2026 shows a company that is selling a vision of $64 billion of latent demand for liquidity in alternative assets while reporting negative revenues of $39.1 million, a net loss of $87.4 million, and operating losses of $166.5 million. Cash and cash equivalents at year-end stood at $2.5 million, barely enough to cover 3.8 days of negative operating cash burn, and liabilities exceeded assets by 41.4%. The board’s latest DEF 14A proposes 1.9 million new restricted stock units for directors and executives, a dilution signal that dwarfs the company’s liquidity buffer. (source: BENF SEC EDGAR 10-K, 2026-06-30, https://www.sec.gov/Archives/edgar/data/1775734/000177573426000018/ben-20260331.htm)

What the company actually does is sell liquidity products and services to funds, limited partners, advisers, and clients through Ben’s Preferred Liquidity Program, and it runs AltData, a data and analytics platform that combines valuation, forecasting, risk analytics, portfolio monitoring, and benchmarking for alternative assets. AltData’s AlphaAlt engine uses Monte Carlo modelling and cash-flow analysis to project outcomes, but the company’s capital expenditure in the period was just $96,000-hardly the mark of a scalable technology stack. The first commercial deployment of the collateral management services offering is announced with fanfare, but the 10-K shows the company is burning cash faster than it can build infrastructure. (source: Liquidity Products and Services, https://www.trustben.com/liquidity-products-and-services/; AltData, https://www.trustben.com/liquidity-products-and-services/altdata/; BENF SEC EDGAR 10-K, 2026-06-30, https://www.sec.gov/Archives/edgar/data/1775734/000177573426000018/ben-20260331.htm)

The filing evidence is unambiguous: Beneficient generated negative revenues of $39.1 million, booked a net loss of $87.4 million, and consumed $38.7 million of operating cash during the year to 31 March 2026. Assets totalled $238.8 million against liabilities of $337.5 million, leaving a tangible equity deficit and a cash pile of $2.5 million. Operating income was a negative $166.5 million, and capital expenditure was a rounding error at $96,000. The company claims a $64 billion addressable market, but the balance sheet it actually collected looks like a start-up that forgot to start up. (source: BENF SEC EDGAR 10-K, 2026-06-30, https://www.sec.gov/Archives/edgar/data/1775734/000177573426000018/ben-20260331.htm)

The company’s governance filings are unusually revealing. A DEF 14A filed on 13 July 2026 proposes 1.9 million restricted stock units for directors and executives, a dilution plan that would materially increase the share count while the operating business continues to post negative cash flow. An 8-K filed on 13 July 2026 discloses the appointment of a new director, and a 5 filing on 9 July 2026 shows a 13D filing indicating substantial shareholder activity. The optics of management desks generosity sit uneasily against the company’s cash runway. (source: BENF DEFA14A, 2026-07-13, https://www.sec.gov/Archives/edgar/data/1775734/000149315226033071/defa14a.htm; BENF 8-K, 2026-07-13, https://www.sec.gov/Archives/edgar/data/1775734/000149315226033069/form8-k.htm; BENF 5, 2026-07-09, https://www.sec.gov/Archives/edgar/data/1775734/000149315226032728/xslF345X06/ownership.xml; BENF SCHEDULE 13D, 2026-07-09, https://www.sec.gov/Archives/edgar/data/1775734/000149315226032723/xslSCHEDULE_13D_X02/primary_doc.xml)

Beneficient’s product announcements are aspirational rather than financial. A press release on 25 June 2026 trumpets the first collateral management services engagement and promises “recurring annual fee revenue,” yet the 10-K shows no revenue line strong enough to offset a $38.7 million operating cash burn. The Preferred Liquidity Program and AltData platform are positioned as breakthrough solutions for alternative asset investors, but the company’s actual capital investment in technology infrastructure is $96,000. The gap between the polished narrative and the prosaic balance sheet is wider than the liquidity gap the company claims to fill. (source: Beneficient Announces First Collateral Management Services Engagement, https://www.trustben.com/insights/beneficient-announces-first-collateral-management-services-engagement/; BENF SEC EDGAR 10-K, 2026-06-30, https://www.sec.gov/Archives/edgar/data/1775734/000177573426000018/ben-20260331.htm)

What changed this week: the DEF 14A, two 8-Ks, and a 5 filing collectively reveal a board moving to approve 1.9 million new restricted stock units and a director appointment, while the 10-K reveals a company that is burning cash faster than it can build revenue. What remains unproven: whether the Preferred Liquidity Program and AltData platform can generate sustainable recurring revenue on a base of negative operating cash flow and a $2.5 million cash pile. What would deepen the file: audited segment-level revenues for the liquidity products vs. the data platform, customer counts by product, and cash-flow break-even guidance tied to concrete milestones. (source: BENF DEFA14A, 2026-07-13, https://www.sec.gov/Archives/edgar/data/1775734/000149315226033071/defa14a.htm; BENF 8-K, 2026-07-13, https://www.sec.gov/Archives/edgar/data/1775734/000149315226033069/form8-k.htm; BENF 5, 2026-07-09, https://www.sec.gov/Archives/edgar/data/1775734/000149315226032728/xslF345X06/ownership.xml; BENF SEC EDGAR 10-K, 2026-06-30, https://www.sec.gov/Archives/edgar/data/1775734/000177573426000018/ben-20260331.htm)

Sources & evidence · 10 links

This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.

Ticker
BENF
Exchange
NASDAQ
Sector
Us Public Equity Directory
Region
United States
Asset class
Equity
Directory source
Nasdaq Trader
SEC CIK
TradingView

BENF technical readout

Trend strength (ADX 14)
15.6
Average true range (ATR 14)
0.3221
ATR as % of price
10.46%
Volatility compression (ATR14/ATR50)
0.89x

Directional bias up. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.

Source authority

BENF evidence rails

Atlas uses the specific public rails available for BENF: SEC EDGAR, Nasdaq Trader, TradingView, FRED. Source names identify the public evidence trail; no partnership, sponsorship or endorsement is implied.

Sources & evidence · 5 rails

Open an Atlas research path on BENF

FreedomCore Atlas can expand this public profile into source-led research files with company snapshots, valuation context, filings and segment detail, source packs, and equity briefs. Each path keeps the underlying public sources visible.

Open Atlas workstation ->
📄
Institutional Research PDF Available for BENF Verified 104-week candle chart, SEC filing evidence & risk register.
Download PDF
Atlas Pro

Keep BENF research in your Atlas archive

Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.

Checking Atlas access...

BENF FAQ

What is Beneficient (BENF)?Beneficient (BENF) has a latest verified close of 3.14, unchanged, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates,...

Beneficient (BENF) has a latest verified close of 3.14, unchanged, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.

What does Atlas show for BENF?Beneficient (BENF) has a latest verified close of 3.14, unchanged, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the...

Beneficient (BENF) has a latest verified close of 3.14, unchanged, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. Atlas files BENF under USA Stocks for browsing.

How often is the BENF page updated?The BENF public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...

The BENF public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.

Which sources does Atlas use for BENF?The BENF file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BENF. SEC EDGAR provides the filing anchor for this issuer. The page separates...

The BENF file starts with SEC EDGAR filings, Nasdaq Trader and TradingView NASDAQ:BENF. SEC EDGAR provides the filing anchor for this issuer. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.

Can Atlas run a full research brief on BENF?Yes. The workstation can open BENF, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Yes. The workstation can open BENF, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.

Is this BENF page investment advice?No. The BENF page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...

No. The BENF page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.

Methodology

This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.

Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.

Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →